1. Medtech Insight
  2. >>Policy & Regulation

Abbott’s Lingo Becomes Second FDA-Cleared OTC Blood Glucose Monitor

 
• By Elizabeth Orr

The FDA has given the green light to over-the-counter sales of Abbott’s Lingo blood glucose monitoring device, which is intended for use by healthy people who want to track the crucial biomarker.

Lingo, line of consumer biowearables to measure glucose, ketones and lactate
• Source: Abbott

The number of over-the-counter blood glucose monitors authorized for market in the US just doubled with the 29 May clearance of Abbott’s Lingo.

The device joins DexCom, Inc.’s Stelo, which received FDA clearance in March and is set to launch this summer....

More from Approvals

More from Policy & Regulation